NovaBay Pharmaceuticals, Inc. Stock Based Compensation

Stock Based Compensation of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Stock Based Compensation growth rates and interactive chart.


Highlights and Quick Summary

  • Stock Based Compensation for the quarter ending June 30, 2022 was $154 Thousand (a -16.3% decrease compared to previous quarter)
  • Year-over-year quarterly Stock Based Compensation decreased by -31.25%
  • Annual Stock Based Compensation for 2021 was $933 Thousand (a 94.78% increase from previous year)
  • Annual Stock Based Compensation for 2020 was $479 Thousand (a 29.11% increase from previous year)
  • Annual Stock Based Compensation for 2019 was $371 Thousand (a -37.54% decrease from previous year)
  • Twelve month Stock Based Compensation ending June 30, 2022 was $792 Thousand (a -15.2% decrease compared to previous quarter)
  • Twelve month trailing Stock Based Compensation decreased by -9.59% year-over-year
Trailing Stock Based Compensation for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
$792 Thousand $934 Thousand $933 Thousand $876 Thousand
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Stock Based Compensation of NovaBay Pharmaceuticals, Inc.

Most recent Stock Based Compensationof NBY including historical data for past 10 years.

Interactive Chart of Stock Based Compensation of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Stock Based Compensation for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $0.15 $0.18
2021 $0.23 $0.22 $0.3 $0.18 $0.93
2020 $0.17 $0.16 $0.09 $0.06 $0.48
2019 $0.01 $0.14 $0.09 $0.12 $0.37
2018 $0.16 $0.17 $0.15 $0.11 $0.59
2017 $-0.35 $0.7 $0.5 $1.19 $2.04
2016 $0.58 $0.65 $0.27 $0.25 $1.75
2015 $0.37 $0.22 $0.5 $0.29 $1.38
2014 $0.27 $0.25 $0.25 $0.28 $1.04
2013 $0.22 $0.22 $0.48 $0.27 $1.18
2012 $0.35 $0.34 $0.39 $0.49 $1.58
2011 $0.33 $1.22

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology